The Practising Law Institute (PLI) has published the 2026 edition of Pharmaceutical and Biotech Patent Law, co-authored and edited by David Barr. Recognized as a leading resource for patent practitioners in the life sciences industry, the treatise provides practical guidance on the legal, scientific, and strategic issues shaping pharmaceutical and biotechnology patent law. The 2026 edition features updates on recent case law and other emerging developments in this rapidly evolving field. In addition, Leah Watson contributed to the publication as the co-author with David of the chapter on Patent Issues Relating to Diagnostics, further highlighting Venable's depth of experience across the life sciences patent landscape.
Click here to read more.